Startups

Intelligence

Membership

Links

Journey

Auxilium Health, born in 2023 by Isaiah Kaiser, PhD (Heartville native), and Aparna Agrawal, PhD, is an Akron biotech spun from University of Akron’s polymer legacy. Its smart biomaterials—color-changing dressings—fight biofoam infections (80% of microbial cases) and heal hard-to-treat wounds like diabetic ulcers, all without antibiotics. $1.5M has been raised to date (oversubscribed pre-seed, 2024), $475K in grants (NSF, Ohio Third Frontier), and a 12-person team (3 full-time scientists, fractionals), it’s Ohio-made at the Cleveland Clinic Global Cardiovascular Innovation Center (GCIC). Working to receive FDA clearance soon and poising themselves to be a retail disrupter in the $25B wound care market.

Location

HQ: Global Cardiovascular Innovation Center in Cleveland

Key Leadership

  • Isaiah Kaiser, PhD (Co-Founder & CEO)
  • Aparna Agrawal, PhD (Co-Founder & CTO)

    Contact: isaiah@auxiliumhealth.xyz | +1 (330) 581-7075

Alignment

Stage: Pre-Seed (post-$1.5M pre-seed, $475K grants)

Industry: Biotechnology (Wound Care Biomaterials)

Key Achievements:

  • $1.5M oversubscribed pre-seed (2024, exceeded $1.2M goal)
  • $275K NSF grant, $200K Ohio Third Frontier grant (2024)
  • Color-changing biomaterials targeting biofoam infections (80% of microbial cases)
  • OhioXcelerate 2024 cohort; IP developed at University of Akron (partial Akron stake)
  • 12-person team (3 FT scientists, consultants) at GCIC

Upcoming Milestones:

  • Pre-clinical validation (animal testing, Q4 2025)
  • Clinical study partnerships with Ohio hospitals (2026)
  • FDA clearance pathway (de novo potential, 2028)

Fundraise Details

  • Target: N/A (post-$1.5M pre-seed; Seed TBD, 2026)
  • Committed: $1.5M (pre-seed, 2024) + $475K grants (NSF, Ohio Third Frontier)
  • Co-investors: Ohio Department of Development, private investors (non-public)
  • Round Open: Closed (pre-seed); Seed TBD (2026 likely)
  • Round Close: N/A
  • Valuation: Undisclosed

Asks

  • Strategic wound care and life sciences insiders (investors, strategics, experts)
  • Intros to decision makers in major hospital networks
  • FDA regulatory and reimbursement experts